Back Bay Life Science Advisors Serves as Advisor to Action Pharma for the Sale of AP214 to Abbott
Back Bay Life Science Advisors served as the primary advisor to Action Pharma and its Board of Directors in the sale of Action Pharma’s renal protectant asset AP214 to Abbott Laboratories, a world leader in renal diseases. Pursuant to the press release dated May 3, 2012 (http://www.abbott.com/news-media/press-releases/abbott-to-acquire-action-pharmas-investigational-compound-ap214-in-phase-2b-development-for-preve.htm), Abbott will pay Action Pharma $110 million for worldwide development and commercialization rights to AP214 – a novel therapeutic for the treatment of acute kidney injury.
Back Bay Life Science Advisors offers strategic consulting for R&D, commercial, corporate, and business development needs of life science companies. Our model, which mandates that scientific, clinical, commercial, and transactional expertise are contiguous, provides clear differentiation in business development execution. This approach provided critical insights as we prepared for and executed this transaction.
Prior to launching the transaction process, Back Bay determined commercial and R&D strategic directions for Action Pharma, performed deep scientific due diligence and clinical trial data analysis as well as additional analysis of regulatory, market, and commercial dynamics for AP214. Consistent with our model, we then served as the embedded business development team for Action Pharma executing on all phases of the transaction process. Our deep insights driven by our collective expertise enabled us to optimally position AP214 among potential partners and ultimately ensured a successful outcome for Action Pharma.
Back Bay Life Science Advisors uniquely delivers on the premise that deep life sciences knowledge, insight, and experience across the technical, clinical and operational spectrum create successful business decisions and implementation. Through expertise across every major phase in a company’s lifecycle, we deliver fully integrated business strategies and execution that produce optimal results and a platform for sustainable, profitable growth.
MassBio Membership gives you:
Purchasing power-MassBio negotiates a broad-based collection of services on behalf of member companies and passes the savings on to its members.
Networking and professional development-MassBio organizes and executes numerous conferences, committee meetings, and networking events throughout the year.
MassBio Signature Events-Attend our Investors Forum, Innovator Roundtables, Pharma Days, our Golf Classic Fundraiser, Policy Leadership Breakfast, and many others.
Public policy & Advocacy-As the state's leading advocate for our life science super cluster, we fight for public policy initiatives and tax incentives in Massachusetts and Washington, D.C., that will enable biotechnology companies to do their best work.
Economic development-MassBio provides expert advice and guidance to help companies find suitable locations and resources as they move to and grow in the Bay State. We make Massachusetts a better place for your business.
Visibility/Resources-Members are listed on a searchable directory that includes a profile and link to the company's website. We highlight your company's latest news by posting to our MassBio member news page. In addition, members can post job openings on our website free!
Educational incentives-We promote education, workforce development and lifelong learning through the MassBioEd Foundation. The foundation customizes training programs for companies and educational institutions and promotes science in the classroom through BioTeach. MassBio members receive a discount on courses offered by the foundation.